LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Apogee Therapeutics (NASDAQ: APGE)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
07/02/2025
Buy
$22.86
7,365
$168K
249,088
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
07/02/2025
Sell
$44.77
6,409
$287K
242,679
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
07/02/2025
Sell
$45.49
2,935
$134K
239,744
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
07/02/2025
Sell
$46.26
746
$35K
238,998
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
07/02/2025
Sell
$22.86
7,365
$168K
164,010
NASDAQ APGE Apogee Therapeutics
Fairmount Funds Management LLC / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
Shah Nimish P / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
McKenna Mark C. / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
JONES WILLIAM A JR / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
Gottesdiener Andrew / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
Fox Jennifer A. / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
Bollinger Lisa / director
06/17/2025
Buy
$41.66
14,461
$602K
14,461
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
06/04/2025
Sell
$36.96
2,725
$101K
241,723
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
05/07/2025
Sell
$35.75
2,725
$97K
244,448